Johannes Hermann

Route 53 Outlook Microsoft Office 365 Amazon AWS Adobe Media Optimizer Vimeo YouTube Google Analytics Mobile Friendly Cedexis Radar Google Tag Manager Workable Typekit Remote AI

biotechnology research breakthrough medicines precision medicine chemoproteomics covalent drug discovery machine learning drug discovery platform kras g12c inhibitor oncology therapeutics targeted protein degradation e3 ligases therapeutic intervention undruggable proteins small molecule drugs anti-cancer therapies biophysical methods analytical methods therapeutic targets proteome access novel therapeutics immunology targets clinical-stage pipeline cancer drivers drug trials pharmaceutical innovation research partnership scientific advisory data-driven approach biochemical screening lead optimization high-throughput screening proteomic capabilities mass spectrometry technology proprietary platform drug development pharmaceutical research collaboration in medicine b cell lymphoma therapy protein research target validation covalent fragment library drug development methodologies therapeutic landscape patient-focused care advanced drug discovery genetically-defined populations precision-based pipeline biotech innovation medicinal chemistry biopharmaceuticals drug discovery oncology immunology targeted therapies innovative therapies undruggable targets partnerships e3 ligase clinical-stage biotech therapeutic focus cancer treatment pharmaceutical collaborations research & development healthcare innovation patient outcomes strategic alliances biotechnology high-impact targets transformative medicine advanced scientific platforms precision oncology artificial intelligence information technology & services hospital & health care